Advertisement

Topics

Midatech Ltd. Company Profile

18:06 EDT 23rd June 2018 | BioPortfolio

Midatech Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products with novel characteristics, functions and applications for a number of industry segments including life sciences, electronics and fine chemicals.


News Articles [61 Associated News Articles listed on BioPortfolio]

Midatech Pharma says revenue rose 37% in first half

“I am pleased to report that Midatech's US commercial business has continued to grow strongly in 2017"

Midatech Pharma selects compound for brain cancer therapy programme

The candidate is based on Midatech's gold nanoparticle technology that targets tumour cells more precisely

Zak Mir: Midatech Pharma looking upwards if it breaks 50-day trend

Midatech Pharma Inc (LON:MTPH) can look towards 118p if it can break through the 50-day moving average suggests technical analyst Zak Mir.

Midatech Pharma to start first-in-man trials of potential new treatment for a childhood brain cancer

Dosing has begun using Midatech’s MTX110 in patients with diffuse intrinsic pontine glioma (DIPG), a highly aggressive strain of the disease

New loan for Midatech promises greater profitability

Midatech Pharma Plc (LON:MTPH, NASDAQMTP) boss tells us how the company has secured a US$15mln, four-year senior loan facility that will be used to bankroll the clinical development of two promising...

Midatech: The Story of a Nanoparticle Start-Up

In this exclusive interview, Fintan Walton talks to Tom Rademacher, President of Midatech, about the formation of the biotech, Professor Rademacher's fifth start-up company. Tom discusses Midatech's b...

Midatech Pharma starts dosing of sustained release tumour treatment in equivalence study

Midatech wants to demonstrate that Q-Octreotide can achieve safe and effective growth hormone levels while also highlighting the advantages of its release system

Full steam ahead at Midatech as cancer treatments edge closer to the clinic

Midatech has three lead R&D programmes: a carcinoid syndrome treatment; a liver cancer drug; and a brain cancer therapy

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Midatech Ltd.

Midatech Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products w...

Midatech Group Ltd.

Midatech Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products with novel character...

More Information about "Midatech Ltd." on BioPortfolio

We have published hundreds of Midatech Ltd. news stories on BioPortfolio along with dozens of Midatech Ltd. Clinical Trials and PubMed Articles about Midatech Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Midatech Ltd. Companies in our database. You can also find out about relevant Midatech Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record